Vertex Pharmaceuticals's chart data is dated 2026-10-08. There is no active technical signal. There are 10 published signal records.
Vertex Pharmaceuticals last closed at $503.25 (-0.47%) on 2026-10-08. Listed on Nasdaq. Trailing 12 months PER is 29.2×. Its overall grade ranks 155 of 738 stocks in Healthcare.
About this company
Vertex Pharmaceuticals last closed at $503.25 (-0.47%) on 2026-10-08. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A- · 155/738
Valuation grade F
Related stocks
- AbbVieCompetitor
낭포성섬유증(CF) 및 면역질환 영역에서 경쟁
- ModernaCompetitor
mRNA 기반 희귀질환·유전질환 치료제 개발 경쟁
- PfizerCompetitor
신약 개발 전반과 일부 희귀질환·진통제 영역에서 경쟁
ETFs holding this stock
VanEck Biotech ETF · Invesco Nasdaq Biotechnology ETF · iShares Biotechnology ETF
Details →About Vertex Pharmaceuticals
- What technical signals does Vertex Pharmaceuticals (VRTX) have?
- Vertex Pharmaceuticals current technical signals: no active technical signal.
- Is Vertex Pharmaceuticals a cup-and-handle pattern?
- No. Vertex Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Vertex Pharmaceuticals?
- Market cap: $127.68B. Trailing 12 months PER: 29.2×. Latest quarter PBR: 6.36×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Vertex Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.